JONATHAN MARTINEZ: Open Payments
NPI 1679764450 · PALMDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,741 in 82 payments from 13 companies in 2025. Trend: 2023 $1,386 · 2024 $1,646 · 2025 $1,741
Food & beverage: $1,741
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 23 | $629 |
| Gilead Sciences, Inc. | 13 | $375 |
| Novo Nordisk Inc | 14 | $209 |
| Otsuka America Pharmaceutical, Inc. | 13 | $180 |
| Lundbeck LLC | 4 | $77 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
| Indivior Inc. | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
Products named: DOVATO, REXULTI, Biktarvy, CABENUVA, Wegovy, COBENFY, RUKOBIA, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
